Which of the following statements about the characteristics of the different histologic types of lung cancer are correct?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 1, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Characteristics of Histological Types of Lung Cancer

Statement (d) is correct: squamous cell carcinoma often presents as a mass with central necrosis, and statement (b) is correct: small cell carcinoma usually presents with mediastinal lymphadenopathy. 1, 2, 3

Analysis of Each Statement

Statement (a): Paraneoplastic manifestations more common in adenocarcinoma - INCORRECT

  • Paraneoplastic syndromes are actually more common in small cell lung cancer (SCLC), not adenocarcinoma 2
  • SCLC frequently produces ectopic hormones, with approximately 2% of patients presenting with Cushing's syndrome from ectopic ACTH production 1
  • Adenocarcinoma does not have a particular association with increased paraneoplastic manifestations compared to other NSCLC subtypes 1, 2

Statement (b): Small cell carcinoma presents with mediastinal lymphadenopathy - CORRECT

  • SCLC characteristically presents with central hilar masses (85%) and mediastinal lymphadenopathy (75%) 3
  • The majority of SCLC patients present with a perihilar mass causing peribronchial compression and obstruction 2
  • Nearly all patients present in advanced stages with disseminated disease, making mediastinal involvement the rule rather than the exception 2, 3
  • At diagnosis, approximately 70% of patients have extensive stage disease that has already spread beyond one hemithorax 3

Statement (c): Small cell carcinoma diagnosed as solitary pulmonary nodule - INCORRECT

  • SCLC is almost never diagnosed as a solitary pulmonary nodule 2, 3, 4
  • SCLC is typically central and manifests as hilar masses, atelectasis, or pneumonia rather than peripheral solitary nodules 4
  • Adenocarcinoma and undifferentiated large cell carcinoma are the histologic types that generally present as peripheral solitary nodules or masses 4
  • SCLC presents with central hilar involvement in 85% of cases, making solitary peripheral presentation extremely uncommon 3

Statement (d): Squamous cell carcinoma presents as mass with central necrosis - CORRECT

  • Squamous cell carcinomas tend to present as near-hilar masses and are strongly associated with central necrosis 1, 2
  • These tumors arise in the setting of bronchial metaplasia and squamous dysplasia in cigarette smokers 1, 2
  • Squamous cell carcinoma is typically central and may manifest as hilar masses, atelectasis, or pneumonia 4
  • The central location and association with chronic bronchitis predisposes to necrosis within the tumor mass 1

Statement (e): Small cell carcinoma diagnosis by bronchoscopy due to localization - CORRECT

  • The central endobronchial location of SCLC makes bronchoscopy an effective diagnostic modality 1, 2, 3
  • For central, endobronchial lesions like SCLC, the overall sensitivity of flexible bronchoscopy for diagnosing lung cancer is 88% 1
  • SCLC diagnosis is confirmed by biopsy of a primary lung mass, thoracic lymph node, or metastatic lesion, with bronchoscopy being the primary approach for central tumors 3
  • The diagnosis of SCLC is most commonly made on small biopsies and cytologic specimens obtained via bronchoscopy 5
  • It is recommended that SCLC diagnosis be confirmed by the least invasive method (including bronchoscopy with TBNA) as dictated by the patient's presentation 1

Key Diagnostic Considerations

Distinguishing SCLC from NSCLC

  • The distinction between SCLC and NSCLC is critical as it determines treatment approach and prognosis 2
  • Interobserver agreement exceeds 95% when diagnostic criteria are satisfied for SCLC 2
  • The accuracy in differentiating between small cell and non-small cell cytology for various diagnostic modalities was 98%, with individual studies ranging from 94% to 100% 1
  • SCLC cells are morphologically small (two to three times the size of small lymphocytes) with scant cytoplasm, high nuclear-to-cytoplasmic ratio, nuclear molding, finely granular chromatin, and absent or inconspicuous nucleoli 2

Common Pitfalls

  • In surgical specimens, SCLC cells may appear larger than in bronchoscopic biopsies, and occasional cells may show prominent nucleoli, but this does not preclude the diagnosis 5
  • A high percentage of SCLC cases (28%) show combinations with NSCLC components, most commonly large cell carcinoma, followed by adenocarcinoma and squamous cell carcinoma 5
  • At least 10% of the tumor should show large cell carcinoma before subclassification as combined SC/LC 5

References

1
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

2
Guideline

Clinical Presentation and Prognosis of Lung Cancer

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4
Research

Bronchogenic carcinoma: radiologic-pathologic correlation.

Radiographics : a review publication of the Radiological Society of North America, Inc, 1994

Related Questions

Is a patient with a history of smoking and small cell lung cancer (SCLC) with right cervical lymphadenopathy a candidate for surgical removal of a benign neoplasm in the right submandibular region?
What is the initial management for hypotension in a patient with small cell lung cancer?
What is the most appropriate immediate action for a patient with stage IIIB small cell lung cancer (SCLC) presenting with new onset back pain and a normal initial neurological examination?
What is the best treatment for small cell lung cancer (SCLC) as a second-line therapy?
What is the management of M1a stage Small Cell Lung Cancer (SCLC) according to the National Comprehensive Cancer Network (NCCN)?
What are the most likely causes and the appropriate initial evaluation and management for a 9‑year‑old girl with four episodes of blood‑tinged cough, no fever, weight loss, or melena, and who has throat congestion and enlarged tonsils?
Do vancomycin and Zocyn (piperacillin/tazobactam) provide coverage against gram‑negative rods?
How can I safely lower a dobutamine infusion in a hemodynamically stable patient (MAP ≥65 mm Hg, heart rate <120 bpm, no ischemia)?
Can a rectal diazepam suppository be used to relax the pelvic floor in a patient with pelvic floor hypertonicity and prior rectal surgeries undergoing biofeedback therapy?
What are the indications, dosing (intramuscular and intravenous), repeat dosing, and monitoring parameters for epinephrine in adult and pediatric overdose patients with life‑threatening hypotension, bronchospasm, or anaphylactoid reactions (e.g., antihistamine, β‑blocker, calcium‑channel‑blocker, or opioid‑induced anaphylaxis)?
What are the possible causes and recommended management for severe nocturnal itching of the shins?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question